Modulating immune-stem cell crosstalk enables robust bone regeneration via tuning compositions of macroporous scaffolds.

IF 6.4 1区 医学 Q1 CELL & TISSUE ENGINEERING
Ni Su, Heena Saqib, Cassandra Villicana, Sungwon Kim, Thomas H Ambrosi, Peyton Freeman, Tayne Kim, Xinming Tong, Manish Ayushman, Charles K F Chan, Fan Yang
{"title":"Modulating immune-stem cell crosstalk enables robust bone regeneration via tuning compositions of macroporous scaffolds.","authors":"Ni Su, Heena Saqib, Cassandra Villicana, Sungwon Kim, Thomas H Ambrosi, Peyton Freeman, Tayne Kim, Xinming Tong, Manish Ayushman, Charles K F Chan, Fan Yang","doi":"10.1038/s41536-025-00421-2","DOIUrl":null,"url":null,"abstract":"<p><p>Following bone injury, macrophages (Mφ) initiate the immune response by secreting signals that recruit mesenchymal stem cells (MSC) and other niche cells to shape healing. Despite its importance, the potential of enhancing bone regeneration by modulating immune-stem cell crosstalk is largely unexplored. Here, we report a macroporous microribbon (µRB) scaffold with tunable ratios of gelatin (Gel) and chondroitin sulfate (CS), achieving rapid endogenous bone regeneration in a critical-sized defect model without exogenous growth factors or cells. The 3D MSC/Mφ co-culture model, but not the mono-culture model, effectively identified Gel50_CS50 as the leading ratio for accelerating bone regeneration in vivo. Single-cell sequencing (scRNAseq) and CellChat analysis revealed that Gel50_CS50 significantly enhanced the cellular crosstalk among Mφ and other bone niche cell types, with signaling pathways linked to anti-inflammation, angiogenesis, and osteogenesis. This study demonstrates Gel50_CS50 µRB as a promising biomaterial-based therapy for treating critical-sized bone defects by modulating cellular crosstalk.</p>","PeriodicalId":54236,"journal":{"name":"npj Regenerative Medicine","volume":"10 1","pages":"33"},"PeriodicalIF":6.4000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12219738/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"npj Regenerative Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41536-025-00421-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Following bone injury, macrophages (Mφ) initiate the immune response by secreting signals that recruit mesenchymal stem cells (MSC) and other niche cells to shape healing. Despite its importance, the potential of enhancing bone regeneration by modulating immune-stem cell crosstalk is largely unexplored. Here, we report a macroporous microribbon (µRB) scaffold with tunable ratios of gelatin (Gel) and chondroitin sulfate (CS), achieving rapid endogenous bone regeneration in a critical-sized defect model without exogenous growth factors or cells. The 3D MSC/Mφ co-culture model, but not the mono-culture model, effectively identified Gel50_CS50 as the leading ratio for accelerating bone regeneration in vivo. Single-cell sequencing (scRNAseq) and CellChat analysis revealed that Gel50_CS50 significantly enhanced the cellular crosstalk among Mφ and other bone niche cell types, with signaling pathways linked to anti-inflammation, angiogenesis, and osteogenesis. This study demonstrates Gel50_CS50 µRB as a promising biomaterial-based therapy for treating critical-sized bone defects by modulating cellular crosstalk.

调节免疫干细胞串扰可通过调节大孔支架的成分实现强健的骨再生。
骨损伤后,巨噬细胞(Mφ)通过分泌信号,招募间充质干细胞(MSC)和其他小生境细胞来启动免疫反应,形成愈合。尽管它很重要,但通过调节免疫干细胞串扰来增强骨再生的潜力在很大程度上尚未被探索。在这里,我们报告了一种大孔微带(µRB)支架,具有可调比例的明胶(Gel)和硫酸软骨素(CS),在没有外源性生长因子或细胞的情况下,在临界尺寸的缺陷模型中实现了快速的内源性骨再生。在3D MSC/Mφ共培养模型中,Gel50_CS50是促进体内骨再生的领先比例,而非单培养模型。单细胞测序(scRNAseq)和CellChat分析显示,Gel50_CS50显著增强了Mφ和其他骨生态位细胞类型之间的细胞串扰,其信号通路与抗炎症、血管生成和成骨有关。该研究表明Gel50_CS50µRB是一种很有前途的生物材料疗法,可以通过调节细胞串扰来治疗临界尺寸的骨缺损。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
npj Regenerative Medicine
npj Regenerative Medicine Engineering-Biomedical Engineering
CiteScore
10.00
自引率
1.40%
发文量
71
审稿时长
12 weeks
期刊介绍: Regenerative Medicine, an innovative online-only journal, aims to advance research in the field of repairing and regenerating damaged tissues and organs within the human body. As a part of the prestigious Nature Partner Journals series and in partnership with ARMI, this high-quality, open access journal serves as a platform for scientists to explore effective therapies that harness the body's natural regenerative capabilities. With a focus on understanding the fundamental mechanisms of tissue damage and regeneration, npj Regenerative Medicine actively encourages studies that bridge the gap between basic research and clinical tissue repair strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信